Integrative Physiology |
From the Department of Pharmacology and Therapeutics (T.N., A.M.M., D.R.V., S.C.), McGill University, Montreal; Departments of Pediatrics, Ophthalmology, and Pharmacology (T.N., A.M.M., I.D., P.H., X.H., F.G., S.C.), Research Center, Hôpital Ste-Justine, Montreal; and Theratechnologies (K.P.), St Laurent, Quebec, Canada.
Correspondence to Sylvain Chemtob, MD, PhD, FRCPC, Departments of Pediatrics, Ophthalmology, and Pharmacology, Research Center of Hôpital Ste-Justine, 3175 Côte Sainte-Catherine, Montreal, Quebec, Canada, H3T 1C5. E-mail chemtobs{at}ere.umontreal.ca
| Abstract |
|---|
|
|
|---|
65
mm Hg; pH
7.2) caused a
2.5-fold increase in CBF at 30 minutes,
which declined to basal values at 3 hours and gradually rose again at 6
and 8 hours; the latter increase was associated with PG elevation,
nitrite formation, eNOS mRNA expression, and in situ NO synthase (NOS)
reactivity (NADPH-diaphorase staining). Subjecting free-floating brain
sections to acidotic conditions increased eNOS expression, the time
course of which was similar to that of CBF increase. Treatment of pigs
with the cyclooxygenase inhibitor diclofenac or the NOS inhibitor
N
-nitro-L-arginine
blunted the initial rise and prevented the secondary CBF increase
during hypercapnic acidosis; neuronal NOS blockers
1-(2-trifluoromethylphenyl) imidazole and 3-bromo-7-nitroindazole were
ineffective. Diclofenac abolished the hypercapnia-induced rise in
cerebrovascular nitrite production, eNOS mRNA expression, and
NADPH-diaphorase reactivity. Acidosis (pH
7.15,
PCO2
40
mm Hg; 6 hours) produced similar increases in prostaglandin
E2 (PGE2) and eNOS mRNA
levels in isolated brain microvessels and in NADPH-diaphorase
reactivity of brain microvasculature; these changes were prevented by
diclofenac, by the receptor-operated Ca2+
channel blocker SK&F96365, and by the KATP
channel blocker glybenclamide. Acidosis increased
Ca2+ transients in brain endothelial cells,
which were blocked by glybenclamide and SK&F96365 but not by
diclofenac. Increased PG-related eNOS mRNA and NO-dependent
vasorelaxation to substance P was detected as well in rat brain exposed
to 6 hours of hypercapnia. PGE2 was the only
major prostanoid that modulated brain eNOS expression during acidosis.
Thus, in prolonged hypercapnic acidosis, the secondary CBF rise is
closely associated with induction of eNOS expression; this seems to be
mediated by PGE2 generated by a
KATP and Ca2+
channeldependent
process.
Key Words: hypercapnia acidosis endothelial nitric oxide synthase prostaglandin E2 potassium channels
| Introduction |
|---|
|
|
|---|
Prostaglandins (PGs), mainly PGI2 and prostaglandin E2 (PGE2), and NO exert a variable contribution on acute hypercapnia-induced increase in CBF.8 9 10 11 12 On the other hand, the mechanisms of the secondary sustained CBF increase are not known. Hypercapnic acidosis increases PGs11 13 and NO.11 14 However, NO synthase (NOS) as well as phospholipase A2 and cyclooxygenase (COX) activities are optimal at basic pHi15 16 ; along these lines, pHo seems to be a major determinant of hypercapnia-induced cerebral vasomotor tone,17 18 19 and bicarbonate can restore CBF to basal levels.18 Acidosis can also stimulate K+ channel opening20 21 22 23 in endothelial cells, leading to increased activities of phospholipase A224 and constitutive NOS.20 25
Complex acute interactions between PGs, NO, and K+ channels have been described26 27 28 ; long-term interactions have also been reported, such as PG induction of endothelial NOS (eNOS) transcription.29 30 We hypothesized that the second CBF rise during prolonged hypercapnia may be triggered by early increases in PGs, which would induce eNOS expression and in turn increase NO release. Our findings disclose for the first time that the second cerebral hyperemia during prolonged hypercapnia is largely contributed by augmented NO release associated with increased eNOS expression, mediated by PGE2 involving K+ and Ca2+ channels.
| Materials and Methods |
|---|
|
|
|---|
-chloralose, and pancuronium (Sigma);
16,16-dimethyl-PGE2,
PGD2, carbaprostacyclin, U46619, and BW245C
(Cayman); 1-(2-trifluoromethylphenyl) imidazole (TRIM) and
3-bromo-7-nitroindazole (Br-7-NI) (Tocris); charybdotoxin and
cromakalim (Calbiochem); SK&F96365 (Biomol);
PGE2 RIA kits (Advanced Magnetics); fluorescent
microspheres (Interactive Medical Technologies); and other
chemicals (Fisher).
Animals
Yorkshire piglets (4 to 6 days old) and
Sprague-Dawley rats (2 to 3 months old) were used according to a
protocol of the Ste-Justine Hospital Animal Care
Committee.
CBF Measurements
CBF was measured in pigs under chloralose sedation by
the microsphere technique as previously
described.31 32
After
catheterization31 32
and stabilization (1.5 hours), fluorescent microspheres were injected
in the left ventricle. After baseline CBF measurements, the gas mixture
was changed to 6% CO2, 73%
N2, and 21% O2 to obtain
stable
PaCO2
values (
65 mm Hg) frequently encountered in the clinical setting;
CBF measurements were repeated 0.5, 3, 6, and 8 hours after initiating
hypercapnia.
Animals were randomly assigned to pretreatment with effective doses of diclofenac (5 mg/kg), L-nitro-arginine (L-NA, 3 mg/kg), neuronal NOS (nNOS) inhibitors TRIM (1 mg/kg followed by 50 µg/kgxmin-1) and Br-7-NI (1 mg/kg followed by 50 µg/kgxmin-1), or saline.32 33 34 At the end of the experiments, animals were killed with pentobarbital (120 mg/kg), brains were removed, and cortex and periventricular regions were weighed. Fluorescence in tissues and reference blood samples were analyzed by Interactive Medical Technologies, and regional CBF was calculated.31 32 Brain PGE2 levels, nitrite production, eNOS mRNA expression, and NADPH-diaphorase reactivity were determined in some animals.
Tissue Preparation and Treatments
Brains (from pig and rat) were quickly placed in
ice-cold artificial cerebral spinal fluid (aCSF) of the following
composition (in mmol/L): 3.0 KCl, 1.5
MgCl2, 1.5 CaCl2, 132
NaCl, 6.6 urea, 1.2
KH2PO4, 24.6
NaHCO3, and 10 glucose; 0.5% FBS; and 0.05%
BSA. Free-floating coronal brain sections (2 to 3 mm) were incubated at
38°C in aCSF for 6 hours under normocapnic, hypercapnic acidotic,
hypercapnic nonacidotic, and normocapnic acidosis, which simulated in
vivo conditions; these conditions were achieved by bubbling
CO2 and adjusting pH with HCl or
NaHCO3. Brain slices were treated with
diclofenac (100 µmol/L) alone or diclofenac plus 1 µmol/L
16,16-dimethyl-PGE2, fenprostalene,
PGD2, BW245C, carbaprostacyclin, or
U46619.
Cerebral Microvessel Preparation and
Treatments
Cerebral microvessels (>70 µm) were
prepared29 35 and
incubated in aCSF for 6 hours under normocapnic or normocapnia acidotic
conditions. Tissues were treated with one of the following (in
µmol/L): 100 diclofenac, 10 glybenclamide, 0.1 charybdotoxin, or 10
SK&F96365. The incubation medium was assayed for
PGE2.26 36
Vasomotor Response of Brain
Microvessels
The brain parenchyma microvascular relaxant response
to the NO-dependent substance
P37 38 was
studied by a video-imaging technique as
described.29
eNOS mRNA Detection by Ribonuclease Protection
Assay and Reverse TranscriptasePolymerase Chain Reaction
(RT-PCR)
eNOS and destrin (control) ribonuclease protection
assays were conducted as
described.29 30 32
To confirm changes in eNOS expression, RT-PCR was also
used.29 30 Total
RNA extracted from rat and pig tissues was transcribed, and eNOS and
18S (internal standard) cDNA fragments were amplified with
Taq DNA polymerase (QuantumRNA
Alternate 18S kit, Ambion). Primers for rat eNOS were
5'-GGAAACGCCAGAGGTACCGG-3' and 5'-AGCCTGGCGC-ACGGTACCTG-3',
and those for pig were 5'-GCTTTTCCC- TGCAGGAGCGAC-3'
and
5'-GCCAGTCTCTGCAGACTCTGG-3'.28 29
Amplified fragments were labeled with
[
-32P]ATP, separated by PAGE, and
quantified using a PhosphorImager (Molecular
Dynamics).
Nitrite Production
NO production was estimated by measuring
nitrite39 as
reported.29 30 32
Cerebrovascular nitrite production in vivo was calculated as the
difference in sagittal sinus and arterial blood concentrationsxtotal
CBF, expressed in ng/min per 100 g tissue, as
reported.32
NADPH-Diaphorase Histochemistry
NADPH-diaphorase reactivity was performed according
to a previously described
method29 40 on
the brain cortex of pigs subjected to high CO2
as well as on brain slices exposed for 6 hours to normocapnic
nonacidotic and acidotic conditions and treated or not with (in
µmol/L) 10 SK&F96365, 100 diclofenac, or 10 glybenclamide. The
intensity of staining in blood vessels was analyzed digitally with
ImagePro +4.1 software (Media Cybernetics). After normalizing for
background tone, equal numbers of pixels taken from cortical
microvessels were compared for significant differences in different
treatment
groups.29 30
Calcium Transients in Cultured Endothelial
Cells
Porcine brain microvascular endothelial cells were
prepared as previously
described.36
[Ca2+]i was
measured by a fura-2acetoxymethyl ester
technique36 in cells
pretreated for 15 minutes with (in µmol/L) 100 diclofenac, 10
glybenclamide, 10 SK&F96365, and 10 SK&F96365 plus 1 µmol/L
K+ channel opener cromakalim. The
[Ca2+]i was
calculated as
reported.36 41
Statistics
CBF data were analyzed by 2-way ANOVA factoring for
time and treatment group. Other data were analyzed by 1-way ANOVA.
Comparison among means was performed by the Dunnett test. Statistical
significance was set at
P<0.05. Data are presented as
mean±SEM.
| Results |
|---|
|
|
|---|
|
|
Brain PG levels increased acutely but tended to decrease for
the remaining 8 hours of hypercapnia, although values remained higher
than basal levels
(Figure 1C
). Pretreatment with diclofenac and L-NA blunted
the early rise in CBF and totally prevented the second CBF increase
noted at 6 and 8 hours of hypercapnia
(Figures 1A
and 1B
); injection of diclofenac 5.5 hours after
exposure to hypercapnia did not affect CBF. The nNOS inhibitors TRIM
and Br-7-NI32 decreased
nitrite production during normocapnia but not hypercapnia but did not
affect the hypercapnia-induced CBF rise
(Figures 1A
, 1B
, and 1D
). PGE2 levels
were diminished by diclofenac
(Figure 1C
) but not by L-NA. Hypercapnia also caused an
increase in cerebrovascular nitrite production, which was blocked by
diclofenac
(Figure 1D
).
Brain NADPH-Diaphorase Reactivity and eNOS mRNA
in Response to Prolonged Hypercapnia
Hypercapnic acidosis of 8 hours duration increased
NADPH-diaphorase reactivity, which was mainly localized in
microvasculature
(Figure 2A
); eNOS mRNA also increased
(Figures 2B
and 2C
). These changes were inhibited by
diclofenac pretreatment
(Figures 2A
through 2C
). Diclofenac starting at 5.5 hours of
hypercapnia did not modify the increase in eNOS mRNA; diclofenac
exerted a negligible effect on NADPH-diaphorase reactivity and eNOS
mRNA under normocapnia.
|
Effects of High CO2 on
eNOS mRNA Expression in Incubated Brain Slices and on NO-Dependent
Relaxant Response of Brain Vasculature
Effects of high CO2 on eNOS mRNA
expression were studied on pig as well as rat brain sections; to assess
whether these changes were reflected in function, vasomotor effects of
the NO-dependent substance
P37 38 were also
tested. Both pig and rat brain sections exposed to high
CO2 for 6 hours exhibited increased eNOS mRNA
and vasorelaxation to substance P, which were prevented by diclofenac
(Figure 3
); relaxation in response to NO-independent
isoproterenol was unaltered by high CO2. Acute
(
30 minutes) exposure to high CO2 had no
effect on the response to substance P.
|
Concentration- and Time-Dependent Effect of
CO2 on eNOS mRNA Expression in Incubated Brain
Slices
Exposure of brain to increasing
CO2 tension for 6 hours caused a
concentration-dependent increase in eNOS mRNA
(Figure 4A
). Acidosis in the presence of normal
CO2 also induced a comparable time-dependent
increase in eNOS expression
(Figure 4B
). Normalization of pH prevented changes in eNOS
mRNA
(Figure 4A
).
|
PG Levels and eNOS Expression in Brain
Microvessels
Acidification of the incubation medium containing brain
microvessels caused an increase in PGE2 in the
6-hour period
(Figure 4C
). Diclofenac, as well as putative
receptor-operated Ca2+ channel blocker
SK&F96365, and KATP (glybenclamide) but not
KCa blocker (charybdotoxin) prevented increases
in PGE2 levels, eNOS mRNA
(Figures 4C
and 4D
), and NO-dependent substance Pevoked
vasorelaxation
(Figure 3B
). SK&F96365 and glybenclamide did not affect eNOS
expression and vasorelaxation under normal pH, whereas cromakalim
increased PGE2, eNOS mRNA, and substance
Pelicited vasorelaxation
(Figures 3B
, 4C
, and 4D
). Modulation of acidosis-induced
changes in eNOS mRNA expression in isolated brain microvessels by COX
and channel blockers were in conformity with NADPH-diaphorase
reactivity in brain slices
(Figure 5
).
|
Effect of Acidosis on Calcium Signaling in
Endothelial Cells
Calcium transients were measured directly on brain
microvascular endothelial cells; smooth muscle and glial cells do not
generate PGs to acidosis.42
Lowering pH of media to
7.1 by HCl or
NaH2PO4 caused a rapid
and marked increase in calcium transients
(Figures 6A
and 6B
) prevented by bicarbonate and dependent
on extracellular calcium entry (blocked by EGTA). SK&F96365 and
glybenclamide, but not diclofenac, prevented acidosis-evoked calcium
transients
(Figures 6A
and 6C
). In addition, the
KATP-channel opener cromakalim stimulated
Ca2+ transients under normal pH; these
effects were also blocked by SK&F96365
(Figures 6B
and 6C
).
|
Effects of PG Analogs on Acidosis-Induced
Changes in eNOS mRNA
The COX product involved in acidosis-induced eNOS
mRNA modulation was investigated; because reactive oxygen species that
can be produced by COX do not play a role in hypercapnia-induced
vasomotor response,43 we
focused on major
prostanoids.29 30
The inhibitory effect of diclofenac on acidosis-induced increase in
eNOS mRNA in brain slices was prevented by concurrent treatment with
16,16-dimethyl-PGE2 (stable
PGE2 analog) but not with
PGD2, fenprostalene, U46619, carbaprostacyclin
or BW245C (these last 4 are stable analogs of
PGF2
, thromboxane
A2, PGI2, and
PGD2)
(Figure 7
).
|
| Discussion |
|---|
|
|
|---|
The effect of acute hypercapnia on CBF is known to be pH
dependent17 18 ;
this also seems to be the case for prolonged hypercapnia, given that
normalization of pH abrogated all changes in CBF. However, despite a
(slight) increase in pH over time during hypercapnia
(Table
),
CBF continued to increase
(Figure 1A
and 1B
); this implies that under these conditions
the effects of acidosis on CBF are delayed consistently with induction
of a slower process such as gene transcription of eNOS. Evidence that
the second hypercapnia-induced hyperemia is largely NO dependent and
appears to result from increased eNOS expression is suggested by the
following observations: (1) cerebrovascular nitrite production rose;
(2) the nonselective NOS inhibitor L-NA prevented the second increase
in CBF
(Figure 1A
and 1B
); (3) in contrast, Br-7-NI and TRIM,
preferential inhibitors of nNOS (as well as of inducible
NOS),48 did not affect the
second rise in CBF; (4) maximum eNOS-dependent vasorelaxation to
substance P37 38
was augmented by prolonged hypercapnia
(Figure 3B
); (5) the late (at
6 hours) increase in CBF
paralleled the time-course profile of eNOS mRNA expression
(Figure 4
); (6) increased eNOS expression was manifested
functionally by concurrent augmented NADPH-diaphorase activity and
maximum eNOS-dependent vasorelaxation to substance
P,37 38
consistent with the relation between expression of eNOS and
hemodynamics49 50 ;
and (7) more importantly, pretreatment but not late treatment with the
COX inhibitor diclofenac abrogated eNOS expression and associated
increased CBF.
A major feature of this study is the role of PGs in
regulating eNOS expression during prolonged hypercapnic acidosis. This
is supported by generation of PGE2 by the
acidosis and effects of the COX inhibitor diclofenac in vivo in animals
ventilated with 6% CO2
(Figure 2
), ex vivo on brain sections
(Figures 3A
, 4A
, and 4B
), and in vitro on isolated
microvessels
(Figures 4C
and 4D
). PGE2 was found to
be the principal PG modulating brain eNOS expression during acidosis.
Furthermore, involvement of K+ channels
during acidosis was itself dependent on PGs
(Figures 4 through 6![]()
![]()
); KATP channel
blockers prevented acidosis-induced calcium transients (required for PG
formation), PGE2 generation, and as a result
eNOS expression. One could presume endothelium to be a major source of
PGs during acidosis, because in contrast to endothelial
cells,19 42
smooth muscle and astroglial cells do not generate PGs in response to
acidosis.42
Few factors are known to modulate eNOS expression. For
example, estrogen51 and
shear stress52 augment and
TNF-
53 and possibly
hypoxia54 decrease eNOS mRNA
expression. More recently, PGE2 and
PGD2 (but not PGI2 or
PGF2
) were found to contribute to
developmental regulation of eNOS
mRNA.29 30 Our
findings are consistent with the latter; moreover, they reveal for the
first time a dominant role for a specific PG, noteworthy
PGE2 in present case, in regulating eNOS
expression during pathophysiological adaption.
Data suggest the apparent activation of
K+ channels by acidosis, which seems to set
off the cascade of intracellular calcium entry, increased PG formation,
and eNOS expression, and the latter in turn results in augmented CBF.
In cerebrovascular cells, acidosis-evoked PGE2
generation and calcium transients were abolished by
KATP (but not KCa)
channel blocker and were reproduced by KATP
openers
(Figures 4 through 6![]()
![]()
), implying hyperpolarization of cells in
this process. Interestingly, hyperpolarization of endothelial cells can
lead to calcium
influx55 56 57
and PG formation26 ; a
posthyperpolarization depolarization may be implicated in this
trigger.58
KATP channels are found on endothelial
cells,59 and acidosis can
stimulate them, but not Kir or
KCa
channels21 22 23 ;
in some species, this may contribute to the early hypercapnia-induced
hemodynamic
changes.20 22
The effects of prolonged hypercapnia on CBF cannot simply be
explained by activation of PG and NO synthase enzymes. This inference
is supported by the failure of COX and NOS inhibitors to further reduce
CBF at 3 hours of hypercapnia and by the inefficacy of late (at 5.5
hours) versus early diclofenac administration on CBF
(Figures 1A
and 1B
). Altogether, the data once more point to
triggering of de novo expression on a pathway involved in control of
cerebral circulation, namely eNOS. The mechanisms for CBF decline after
its first peak are not clear but may be contributed to by decreased
formation of PGs (and possibly NO)
(Figures 1C
and 1D
) before augmented eNOS
expression.
In conclusion, the present study discloses a major and previously unexplored mechanism for a second cerebral hyperemia during sustained hypercapnia, which is mediated by NO through a process dependent on interaction between KATP channels and PGs and involving the induction of eNOS expression. We postulate that in chronic lung disease, the mechanisms identified may provide protection to the brain by enhancing cerebral hemodynamics when the latter is being compromised by impaired venous outflow due to augmented lung volume and by polycythemic hyperviscosity.4 6
| Acknowledgments |
|---|
| Footnotes |
|---|
Received May 26, 2000; revision received October 13, 2000; accepted October 13, 2000.
| References |
|---|
|
|
|---|
receptor density in brain microvessels
of pigs. Br J Pharmacol. 1994;112:5964.[Medline]
[Order article via Infotrieve]
on retinal
vessels. Am J Physiol. 1998;274:R1406R1416.This article has been cited by other articles:
![]() |
K. C. Peebles, A. M. Richards, L. Celi, K. McGrattan, C. J. Murrell, and P. N. Ainslie Human cerebral arteriovenous vasoactive exchange during alterations in arterial blood gases J Appl Physiol, October 1, 2008; 105(4): 1060 - 1068. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-M. Hristovska, L. E. Rasmussen, P. B.L. Hansen, S. S. Nielsen, R. M. Nusing, S. Narumiya, P. Vanhoutte, O. Skott, and B. L. Jensen Prostaglandin E2 Induces Vascular Relaxation by E-Prostanoid 4 Receptor-Mediated Activation of Endothelial Nitric Oxide Synthase Hypertension, September 1, 2007; 50(3): 525 - 530. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. N. Ainslie, C. Murrell, K. Peebles, M. Swart, M. A. Skinner, M. J. A. Williams, and R. D. Taylor Vascular: Early morning impairment in cerebral autoregulation and cerebrovascular CO2 reactivity in healthy humans: relation to endothelial function Exp Physiol, July 1, 2007; 92(4): 769 - 777. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lavi, D. Gaitini, V. Milloul, and G. Jacob Impaired cerebral CO2 vasoreactivity: association with endothelial dysfunction Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1856 - H1861. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. T. Hare, C. D. Mazer, W. Mak, R. M. Gorczynski, K. M. Hum, S. Y. Kim, L. Wyard, A. Barr, R. Qu, and A. J. Baker Hemodilutional anemia is associated with increased cerebral neuronal nitric oxide synthase gene expression J Appl Physiol, May 1, 2003; 94(5): 2058 - 2067. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. S. Lin, Q. Gu, and L.-Y. Lee Activation of Dopamine D2-like Receptors Attenuates Pulmonary C-Fiber Hypersensitivity in Rats Am. J. Respir. Crit. Care Med., April 15, 2003; 167(8): 1096 - 1101. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Baines and P. Ho Glucose stimulates O2 consumption, NOS, and Na/H exchange in diabetic rat proximal tubules Am J Physiol Renal Physiol, August 1, 2002; 283(2): F286 - F293. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mizuno, Y. Demura, S. Ameshima, S. Okamura, I. Miyamori, and T. Ishizaki Alkalosis stimulates endothelial nitric oxide synthase in cultured human pulmonary arterial endothelial cells Am J Physiol Lung Cell Mol Physiol, July 1, 2002; 283(1): L113 - L119. [Abstract] |